Colin Shannon - Jun 15, 2021 Form 4/A - Amendment Insider Report for PRA Health Sciences, Inc. (PRAH)

Role
President & CEO, Director
Signature
By: /s/ Christopher L. Gaenzle, by power of attorney
Stock symbol
PRAH
Transactions as of
Jun 15, 2021
Transactions value $
-$1,353,611
Form type
4/A - Amendment
Date filed
6/30/2021, 12:27 PM
Date Of Original Report
Jun 17, 2021
Previous filing
Jun 3, 2021
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAH Common Stock Sale -$1.19M -7.13K -13.06% $166.42 47.5K Jun 16, 2021 Direct F1, F2, F5
transaction PRAH Common Stock Sale -$94.4K -564 -1.19% $167.39 46.9K Jun 16, 2021 Direct F1, F3, F5
transaction PRAH Common Stock Sale -$72.3K -430 -0.92% $168.13 46.5K Jun 16, 2021 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.06 to $167.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3) and (4) of this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.09 to $167.95, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.08 to $168.25, inclusive.
F5 The number of shares reported in Column 5 reflects the number of shares beneficially owned by the reporting person as of the filing date of this Form 4, which reflects the transactions reported on the Form 4 filed by the reporting person on June 21, 2021.